iTeos Therapeutics Inc. (ITOS)
7.67
0.01 (0.13%)
At close: Jan 15, 2025, 11:41 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -112.64M | 96.65M | 214.52M | -38.03M | -22.45M | -18.06M |
| Depreciation & Amortization | 898.00K | 803.00K | 603.00K | 535.00K | 611.00K | 505.00K |
| Stock-Based Compensation | 27.02M | 21.56M | 13.79M | 4.29M | 809.00K | 112.00K |
| Other Working Capital | -11.84M | -231.25M | 281.93M | 7.65M | -927.00K | -1.54M |
| Other Non-Cash Items | -7.20M | -1.72M | 12.00K | -35.00K | -10.00K | 69.00K |
| Deferred Income Tax | -3.04M | n/a | n/a | -1.26M | -1.02M | 130.00K |
| Change in Working Capital | -8.80M | -228.49M | 284.21M | 9.33M | -1.08M | -1.86M |
| Operating Cash Flow | -103.76M | -111.19M | 513.14M | -25.18M | -23.14M | -19.10M |
| Capital Expenditures | -2.97M | -938.00K | -1.18M | -356.00K | -721.00K | -226.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -290.54M | -445.00M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 366.26M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -99.00K | -120.00K | -61.00K | -21.00K | -205.00K | -73.00K |
| Investing Cash Flow | 72.66M | -446.06M | -1.24M | -377.00K | -926.00K | -299.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -226.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.11M | 1.98M | 3.66M | 126.68M | 22.54M | 23.51M |
| Financial Cash Flow | 1.11M | 1.98M | 3.66M | 340.34M | 22.54M | 23.51M |
| Net Cash Flow | -33.59M | -563.80M | 512.38M | 316.46M | -2.06M | 3.24M |
| Free Cash Flow | -106.72M | -112.13M | 511.96M | -25.53M | -23.87M | -19.32M |